Search Results - "Sherwani, Zohaib"

Prognostic Effect of Mismatch Repair Status in Early-Stage Endometrial Cancer Treated With Adjuvant Radiation: A Multi-institutional Analysis by Hathout, Lara, Sherwani, Zohaib K., Alegun, Josephine, Ohri, Nisha, Fields, Emma C., Shah, Shubhangi, Beriwal, Sushil, Horne, Zachary D., Kidd, Elizabeth A., Leung, Eric W., Song, Jiheon, Taunk, Neil K., Chino, Junzo, Huang, Christina, Russo, Andrea L., Dyer, Michael, Li, Jessie, Albuquerque, Kevin V., Damast, Shari

“…The aim of this work was to report the effect of mismatch repair (MMR) status on outcomes of patients with stage I-II endometrioid endometrial adenocarcinoma…”
Get full text

Delayed surgical repair of the deltoid following acromioplasty: a case report by Sherwani, Zohaib, Kelley, Chase, Farooq, Hassan, Garbis, Nickolas G.

“…Currently, the literature contains few studies that describe any potential complications following arthroscopic acromioplasty. Because part of the anterior…”
Get full text

Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval by Harris, Alexander A, Korpics, Mark, Sherwani, Zohaib, Farooq, Ahmer, Baldea, Kristin G, Flanigan, Robert, Harkenrider, Matthew M, Solanki, Abhishek A

“…High-dose-rate (HDR) brachytherapy is an effective method of treating localized prostate cancer. There are limited data on the relationship between implant…”
Get full text

Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review by Kumar, Ritesh, Sherwani, Zohaib, Lopez, Melissa, Vergalasova, Irina, Zhang, Xinxin, Eckroate, Brett, Hollingsworth, Jessie, Girda, Eugenia, Hathout, Lara

“…Brachytherapy (BT) is an integral component of treatment for patients with locally advanced cervical cancer, significantly improving local control and overall…”
Get full text

Disparities in Brachytherapy Utilization in Cervical Cancer in the United States: A Comprehensive Literature Review by Kumar, Ritesh, Sherwani, Zohaib, Lopez, Melissa, Vergalasova, Irina, Zhang, Xinxin, Eckroate, Brett, Hollingsworth, Jessie, Girda, Eugenia, Hathout, Lara

“…(Abstracted from Gynecol Oncol 2024;179:79–84) Advanced cervical cancer is commonly treated with concurrent chemotherapy and external beam radiation therapy…”
Get full text

First Results of the Primary Outcome of a Phase 2 Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Patients With Breast Cancer by Yehia, Zeinab Abou, Sherwani, Zohaib, Chakraborty, Molly, Ohri, Nisha, Grann, Alison, Eladoumikdachi, Firas, Kowzun, Maria, Kumar, Shicha, Potdevin, Lindsay, Blackwood, Michele, Toppmeyer, Deborah, Haffty, Bruce G.

“…A radiation therapy (RT) boost to the tumor bed is an important component of breast-conserving therapy in early breast cancer. This prospective phase 2 study…”
Get full text

Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach by Sherwani, Zohaib, Parikh, Shreel, Yegya-Raman, Nikhil, McKenna, Kelly, Deek, Matthew, Jabbour, Salma, Hathout, Lara

“…Historically, the role of radiation in gynecological metastatic disease involved palliation for pain or bleeding. Stereotactic Body Radiation Therapy (SBRT)…”
Get full text

Impact of the COVID-19 pandemic on brachytherapy and cancer patient outcomes: A systematic review by Parikh, Shreel, Zhang, Yingting, Sherwani, Zohaib, Kumar, Ritesh, Ohri, Nisha, Jan, Imraan, Vergalasova, Irina, Jabbour, Salma, Hathout, Lara

“…To assess the impact of the COVID-19 pandemic on the use of brachytherapy in patients with gynecologic and prostate cancers including treatment delays,…”
Get full text

Abstract PO4-22-04: Evaluation of acute toxicity in breast cancer patients receiving concurrent capecitabine and radiation by Shalaby, Ahmed, Sherwani, Zohaib, Hathout, Lara, Jan, Imraan, Haffty, Bruce, George, Mridula, Kumar, Shicha, Omene, Coral, Toppmeyer, Deborah, Ohri, Nisha

“…Purpose: Adjuvant capecitabine has been shown to improve disease-free survival and overall survival in breast cancer patients who have residual disease after…”
Get full text